Expression of the insulin-like growth factor-I receptor and proapoptotic Bax and Bak proteins in human colorectal cancer

Annals of the New York Academy of Sciences

Volumn 1030, Issue , 2004, Pages 377-383

  Koda, Mariusz ^a   Reszec, Joanna ^a   Sulkowska, Mariola ^a   Kanczuga Koda, Luiza ^a   Sulkowski, Stanislaw ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Apoptosis; Bak; Bax; Colorectal cancer; IGF IR

Indexed keywords

AVIDIN; BIOTIN; PEROXIDASE; PROTEIN BAK; PROTEIN BAX; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ADULT; AGED; APOPTOSIS; CANCER GRADING; CANCER STAGING; CARCINOGENESIS; COLON MUCOSA; COLORECTAL CARCINOMA; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION;

EID: 15044352178     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1329.047     Document Type: Conference Paper

References (28)

1. GRYFE, R., C. SWALLOW, B. BAPAT, et al. 1997. Molecular biology of colorectal cancer. Curr. Probl. Cancer 21: 233-300.
2. WATSON, D.S., I. BROTHERICK, B.K. SHENTON, et al. 1999. Growth dysregulation and p53 accumulation in human primary colorectal cancer. Br. J. Cancer 80: 1062-1068.
3. MOSCHOS, S.J. & C.S. MANTZOROS. 2002. The role of the IGF system in cancer: from basic to clinical studies and clinical applications. Oncology 63: 317-332.
4. HAKAM, A., T.J. YEATMAN, L. LU, et al. 1999. Expression of insulin-like growth factor-1 receptor in human colorectal cancer. Hum. Pathol. 30: 1128-1133.
5. WEBER, M.M., C. FOTTNER, S.B. LIU, et al. 2002. Overexpression of the insulin-like growth factor I receptor in human colon carcinomas. Cancer 95: 2086-2095.
6. REINMUTH, N., F. FAN, W. LIU, et al. 2002. Impact of insulin-like growth factor receptor-I function on angiogenesis, growth, and metastasis of colon cancer. Lab. Invest. 82: 1377-1389.
7. PETERS, G., S. GONGOLL, C. LANGNER, et al. 2003. IGF-1R, IGF-1 and IGF-2 expression as potential prognostic and predictive markers in colorectal-cancer. Virchows Arch. 443: 139-145.
8. REED, J.C. 1998. Bcl-2 family proteins. Oncogene 17: 3225-3236.
9. MIYASHITA, T., S. Krajewski, M. Krajewska, et al. 1994. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9: 1799-1805.
10. TEIXEIRA, C., J.C. REED, M.A. PRATT, et al. 1995. Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res. 55: 3902-3907.
11. ADAMS, T.E., V.C. EPA, T.P. GARRETT, et al. 2000. Structure and function of the type 1 insulin-like growth factor receptor. Cell. Mol. Life Sci. 57: 1050-1093.
12. DEY, B.R., S.L. SPENCE, P. NISSLEY, et al. 1998. Interaction of human suppressor of cytokine signaling (SOCS)-2 with the insulin-like growth factor-I receptor. J. Biol. Chem. 273: 24095-24101.
13. ZONG, C.S., J. CHAN, D.E. LEVY, et al. 2000. Mechanism of STAT3 activation by insulin-like growth factor I receptor. J. Biol. Chem. 275: 15099-15105.
14. KAWAKAMI, A., T. NAKASHIMA, M. TSUBOI, et al. 1998. Insulin-like growth factor I stimulates proliferation and Fas-mediated apoptosis of human osteoblasts. Biochem. Biophys. Res. Commun. 247: 46-51.
15. RAILE, K., R. HILLE, S. LAUE, et al. 2003. Insulin-like growth factor I (IGF-I) stimulates proliferation but also increases caspase-3 activity, annexin-V binding, and DNA fragmentation in human MG63 osteosarcoma cells: co-activation of pro- and antiapoptotic pathways by IGF-I. Horm. Metab. Res. 35: 786-793.
16. WU, J., K. HAUGK & S.R. PLYMATE. 2003. Activation of pro-apoptotic p38-MAPK pathway in the prostate cancer cell line M12 expressing a truncated IGF-IR. Horm. Metab. Res. 35: 751-757.
17. KODA, M., S. SULKOWSKI, C. GAROFALO, et al. 2003. Expression of the insulin-like growth factor-I receptor in primary breast cancer and lymph node metastases: correlations with estrogen receptors α and β. Horm. Metab. Res. 35: 794-801.
18. FREIER, S., O. WEISS, M. ERAN, et al. 1999. Expression of the insulin-like growth factors and their receptors in adenocarcinoma of the colon. Gut 44: 704-708.
19. ADENIS, A., J.P. PEYRAT, B. HECQUET, et al. 1995. Type I insulin-like growth factor receptors in human colorectal cancer. Eur. J. Cancer 31A: 50-55.
20. ZENILMAN, M.E. & W. GRAHAM. 1997. Insulin-like growth factor I receptor messenger RNA in the colon is unchanged during neoplasia. Cancer Invest. 15: 1-7.
21. MISHRA, L., B. BASS, B.S. OOI, et al. 1998. Role of insulin-like growth factor-I (IGF-I) receptor, IGF-I, and IGF binding protein-2 in human colorectal cancers. Growth Horm. IGF Res. 8: 473-479.
22. KRAJEWSKA, M., S.F. MOSS, S. KRAJEWSKI, et al. 1996. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas. Cancer Res. 56: 2422-2427.
23. OGURA, E., H. SENZAKI, D. YAMAMOTO, et al. 1999. Prognostic significance of Bcl-2, Bcl-xL/S, Bax and Bak expressions in colorectal carcinomas. Oncol. Rep. 6: 365-369.
24. JANSSON, A. & X.F. SUN. 2002. Bax expression decreases significantly from primary tumor to metastasis in colorectal cancer. J. Clin. Oncol. 20: 811-816.
25. SEKHARAM, M., A. NASIR, H.E. KAISER, et al. 2003. Insulin-like growth factor 1 receptor activates c-SRC and modifies transformation and motility of colon cancer in vitro. Anticancer Res. 23: 1517-1524.
26. DUDEK, H., S.R. DATTA, T.F. FRANKE, et al. 1997. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275: 661-665.
27. DATTA, S.R., H. DUDEK, X. TAO, et al. 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91: 231-241.
28. YANG, E., J. ZHA, J. JOCKEL, et al. 1995. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell 80: 285-291.